Table 4.
Results from Analyses of Pain Growth Factors Predicting 12-Month Drinking Outcomes Mediated by Negative Affect in UKATT
| UKATT | B (SE; 95% CI) | R2 | |
|---|---|---|---|
| 12-month % Drinking Days (PDD) (RMSEA=0.08 (90% CI: 0.06, 0.09), CFI = 0.96) | .19 | ||
| Baseline PDD | 0.30 (0.07)** | ||
| Pain interference and intensity intercept | 0.09 (0.03)* | ||
| Pain interference and intensity slope | −0.03 (0.16) | ||
| Negative affect intercept | −0.08 (0.04)* | ||
| Negative affect slope | 0.19 (0.04)** | ||
| Pain intercept → Affect intercept → PDD Mediation | −.01 (.01; 95% CI: −.03, −.001)* | ||
| Pain slope → Affect slope → PDD Mediation | .008 (.002; 95% CI: .004, .012)* | ||
| 12-month Drinks/Drinking Day (DDD) (RMSEA=0.08 (90% CI: 0.06, 0.09), CFI = 0.96) | .29 | ||
| Baseline DDD | 0.28 (0.06)** | ||
| Pain interference and intensity intercept | 0.004 (0.01) | ||
| Pain interference and intensity slope | 0.002 (0.05) | ||
| Negative affect intercept | 0.02 (0.02) | ||
| Negative affect slope | 0.06 (0.02)** | ||
| Pain intercept → Affect intercept → DDD Mediation | .004 (.003; 95% CI: −.001, .01) | ||
| Pain slope → Affect slope → DDD Mediation | .002 (.001; 95% CI: .001, .004)* | ||
| 12-month % Heavy Drinking Days (PHDD) (RMSEA=0.08 (90% CI: 0.06, 0.09), CFI= .96) | .23 | ||
| Baseline PHDD | 0.28 (0.07)** | ||
| Pain interference and intensity intercept | 0.07 (0.03)** | ||
| Pain interference and intensity slope | 0.01 (0.12) | ||
| Negative affect intercept | −0.05 (0.04) | ||
| Negative affect slope | 0.21 (0.04)** | ||
| Pain intercept → Affect intercept → PHDD Mediation | −.009 (.01; 95% CI: −.02, .004) | ||
| Pain slope → Affect slope → PHDD Mediation | .009 (.002; 95% CI: .005, .01)** | ||
| 12-month Maximum Drinks/Day (MXD) (RMSEA=0.08 (90% CI: 0.06, 0.09), CFI= .96) | .27 | ||
| Baseline MXD | 0.30 (0.05)** | ||
| Pain interference and intensity intercept | 0.005 (0.01) | ||
| Pain interference and intensity slope | 0.00 (0.07) | ||
| Negative affect intercept | 0.03 (0.02) | ||
| Negative affect slope | 0.07 (0.02)** | ||
| Pain intercept → Affect intercept → MXD Mediation | .01 (.004; 95% CI: −.002, .01) | ||
| Pain slope → Affect slope → MXD Mediation | .003 (.001; 95% CI: .001, .01)** | ||
*
p < 0.05;
**
p < 0.01;
B = unstandardized regression coefficient (SE = Standard Error); 95% CI = 95% confidence interval of mediated effect.